39 results on '"Hryckowian, Andrew J."'
Search Results
2. A randomized controlled trial of an oral probiotic to reduce antepartum group B Streptococcus colonization and gastrointestinal symptoms
3. Oxidative ornithine metabolism supports non-inflammatory C. difficile colonization
4. A gut bacterial pathway metabolizes aromatic amino acids into nine circulating metabolites
5. Re-framing the importance of Group B Streptococcus as a gut-resident pathobiont
6. The Clinical Drug Ebselen Attenuates Inflammation and Promotes Microbiome Recovery in Mice after Antibiotic Treatment for CDI
7. Exogenous butyrate inhibits butyrogenic metabolism and alters virulence phenotypes in Clostridioides difficile
8. Western diet regulates immune status and the response to LPS-driven sepsis independent of diet-associated microbiome
9. Long-term persistence of crAss-like phage crAss001 is associated with phase variation in Bacteroides intestinalis
10. Phase-variable capsular polysaccharides and lipoproteins modify bacteriophage susceptibility in Bacteroides thetaiotaomicron
11. Gut Microbiota-Produced Succinate Promotes C. difficile Infection after Antibiotic Treatment or Motility Disturbance
12. Insertion sequence driven evolution of the microbiota revealed by a novel metagenomics pipeline
13. Exogenous butyrate inhibits butyrogenic metabolism and alters expression of virulence genes inClostridioides difficile
14. Microbiota-accessible carbohydrates suppress Clostridium difficile infection in a murine model
15. Butyrate Differentiates Permissiveness to Clostridioides difficile Infection and Influences Growth of Diverse C. difficile Isolates
16. Butyrate differentiates permissiveness to Clostridioides difficile infection and influences growth of diverse C. difficile isolates
17. Independent host- and bacterium-based determinants protect a model symbiosis from phage predation
18. A short chain fatty acid–centric view of Clostridioides difficile pathogenesis
19. High-throughput low-cost nl-qPCR for enteropathogen detection: A proof-of-concept among hospitalized patients in Bangladesh
20. Microbiome Management for the 21st Century and Beyond
21. Independent host- and bacterium-based determinants protect a model symbiosis from phage predation
22. Additional file 1 of Long-term persistence of crAss-like phage crAss001 is associated with phase variation in Bacteroides intestinalis
23. Long-term persistence of crAss-like phage crAss001 is associated with phase variation in Bacteroides intestinalis
24. Bacteroides thetaiotaomicron-Infecting Bacteriophage Isolates Inform Sequence-Based Host Range Predictions
25. The clinical drug candidate ebselen attenuates inflammation and promotes microbiome recovery after antibiotic treatment for Clostridium difficile infection
26. Identification of Widespread Antibiotic Exposure in Patients With Cholera Correlates With Clinically Relevant Microbiota Changes
27. Multiple phase-variable mechanisms, including capsular polysaccharides, modify bacteriophage susceptibility in Bacteroides thetaiotaomicron
28. Microbiota Accessible Carbohydrates SuppressClostridium difficilein a Murine Model
29. The emerging metabolic view of Clostridium difficile pathogenesis
30. A small-molecule antivirulence agent for treating Clostridium difficile infection
31. dsdA Does Not Affect Colonization of the Murine Urinary Tract by Escherichia coli CFT073
32. IraL Is an RssB Anti-adaptor That Stabilizes RpoS during Logarithmic Phase Growth in Escherichia coli and Shigella
33. RpoS Contributes to Phagocyte Oxidase-Mediated Stress Resistance during Urinary Tract Infection by Escherichia coli CFT073
34. Comparative Genomic Analysis of 60 Mycobacteriophage Genomes: Genome Clustering, Gene Acquisition, and Gene Size
35. Exploring the Mycobacteriophage Metaproteome: Phage Genomics as an Educational Platform
36. IraL Is an RssB Anti-adaptor That Stabilizes RpoS during Logarithmic Phase Growth in Escherichia coliand Shigella
37. A metagenomics pipeline reveals insertion sequence-driven evolution of the microbiota.
38. Determinants of Gastrointestinal Group B Streptococcus Carriage in Adults.
39. Exogenous butyrate inhibits butyrogenic metabolism and alters expression of virulence genes in Clostridioides difficile .
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.